Abstract
A direct comparison between American pharmaceutical and medical device clinical good manufacturing practices (cGMPs) versus International Standards Organization (ISO) 9002 has been studied via a third party audit of an industrial contract manufacturer by a generic pharmaceutical corporation. To meet future international harmonization needs, the contract manufacturer had set a goal to obtain ISO 9002 approval. As its market for components of medical devices expanded, management soon envisioned expansion into pharmaceutical production.Medical device cGMP regulations were similar to the specifications set by ISO 9002. Pharmaceutical cGMPs were seen as a deviation from the standard operating procedures for ISO 9002.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
